Sygnature Discovery Is An Integrated Drug Discovery Contract Research Organizationcrobased In The Ukfounded In 2004The Company Provides A Comprehensive Range Of Drug Discovery And Preclinical Services To Pharmaceutical Companiesbiotechsand Not For Profit Organizationswith A Strong Focus On Collaborationsygnature Offers Expertise In Various Therapeutic Areasincluding In Vivo Pharmacologydrug Formulationbiosciencechemistryand Drug Metabolism And Pharmacokineticsdmpkthe Cellular Pharmacology Services At Sygnature Discovery Include Cell Line Generationion Channel Drug Discoverygpcr Drug Discoverytransporter Drug Discoveryand Drug Discovery Screeningthese Services Are Designed To Support High Quality Research And Development In Drug Discoverysygnature Operates From Advanced Facilities In Nottingham And Cheshireukand Has Expanded Its Capabilities Through Strategic Acquisitionsenhancing Its Service Offerings In The Drug Discovery Field
